Simplify Asset Management Inc. Buys Shares of 37,948 Establishment Labs Holdings Inc. $ESTA

Simplify Asset Management Inc. bought a new position in Establishment Labs Holdings Inc. (NASDAQ:ESTA) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 37,948 shares of the company’s stock, valued at approximately $1,555,000. Simplify Asset Management Inc. owned 0.13% of Establishment Labs as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Brian Low Financial Group LLC purchased a new stake in Establishment Labs in the third quarter worth about $223,000. ARS Investment Partners LLC grew its stake in shares of Establishment Labs by 50.0% during the 3rd quarter. ARS Investment Partners LLC now owns 9,750 shares of the company’s stock valued at $400,000 after acquiring an additional 3,250 shares during the period. Guided Capital Wealth Management LLC increased its holdings in Establishment Labs by 3.8% in the 3rd quarter. Guided Capital Wealth Management LLC now owns 51,650 shares of the company’s stock worth $2,117,000 after acquiring an additional 1,908 shares in the last quarter. Patriot Financial Group Insurance Agency LLC raised its stake in Establishment Labs by 5.8% during the 3rd quarter. Patriot Financial Group Insurance Agency LLC now owns 6,375 shares of the company’s stock worth $261,000 after acquiring an additional 350 shares during the period. Finally, Osaic Holdings Inc. lifted its holdings in Establishment Labs by 900.0% during the second quarter. Osaic Holdings Inc. now owns 2,000 shares of the company’s stock valued at $85,000 after purchasing an additional 1,800 shares in the last quarter. 72.91% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently commented on ESTA. Needham & Company LLC raised their price objective on shares of Establishment Labs from $70.00 to $84.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. JPMorgan Chase & Co. raised their price target on Establishment Labs from $71.00 to $80.00 and gave the company an “overweight” rating in a report on Wednesday, December 17th. Canaccord Genuity Group boosted their price objective on Establishment Labs from $72.00 to $85.00 and gave the company a “buy” rating in a research report on Wednesday, December 17th. Mizuho increased their target price on Establishment Labs from $85.00 to $90.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 17th. Finally, Wall Street Zen raised Establishment Labs from a “sell” rating to a “hold” rating in a report on Sunday, October 19th. Six research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $78.14.

Establishment Labs Trading Down 4.6%

Shares of ESTA stock opened at $72.92 on Tuesday. The company has a current ratio of 3.33, a quick ratio of 2.10 and a debt-to-equity ratio of 15.06. The stock has a market capitalization of $2.12 billion, a price-to-earnings ratio of -25.68 and a beta of 1.01. Establishment Labs Holdings Inc. has a 12-month low of $26.56 and a 12-month high of $78.24. The stock’s 50-day moving average price is $65.31 and its 200-day moving average price is $49.47.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings results on Wednesday, November 5th. The company reported ($0.38) earnings per share for the quarter, beating the consensus estimate of ($0.54) by $0.16. The business had revenue of $53.78 million during the quarter, compared to analysts’ expectations of $52.28 million. Establishment Labs had a negative return on equity of 235.45% and a negative net margin of 43.45%.The firm’s revenue for the quarter was up 33.8% compared to the same quarter last year. During the same quarter last year, the business posted ($0.59) EPS. Equities research analysts predict that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Establishment Labs Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.